Reporting owner

NELSEN ROBERT

Reporting owner CIK 0001219042 · Director · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 7 of 7 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)NELSEN ROBERTStock award
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTPurchase
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 27, 2025Neumora Therapeutics, Inc.Common StockCRANDELL KEITH · NELSEN ROBERT · BYBEE CLINTON · GILLIS STEVEN · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: CITY THERAPEUTICS, INC.CTY · company listings
NELSEN ROBERTDirector · 10% owner
Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade: CITY THERAPEUTICS, INC.CTY · company listings
NELSEN ROBERTDirector · 10% owner
PurchaseCommon StockNon-derivative security · Code P170,00018Value: 3,060,000Currency not specifiedView ↗
Trade: CITY THERAPEUTICS, INC.CTY · company listings
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C2,027,006Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: CITY THERAPEUTICS, INC.CTY · company listings
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C5,482,309Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: CITY THERAPEUTICS, INC.CTY · company listings
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C3,294,900Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Neumora Therapeutics, Inc.NMRA · company listings
NELSEN ROBERT10% owner
BYBEE CLINTON10% owner
GILLIS STEVEN10% owner
Joint filing · amounts unallocated
PurchaseCommon StockNon-derivative security · Code P1,915,7002.61Value: 4,999,977Currency not specifiedView ↗